NEO-CYTAMEN

This brand name is authorized in Ireland, United Kingdom

Active ingredients

The drug NEO-CYTAMEN contains one active pharmaceutical ingredient (API):

1 Vitamin B12a
UNII Q40X8H422O - HYDROXOCOBALAMIN

Hydroxocobalamin is a cyanide antidote. Its action in the treatment of cyanide poisoning is based on its ability to bind cyanide ions. Each hydroxocobalamin molecule can bind one cyanide ion by substituting it for the hydroxo ligand linked to the trivalent cobalt ion, to form cyanocobalamin, which is then excreted in the urine.

Read about Vitamin B12a

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NEO-CYTAMEN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B03BA03 Hydroxocobalamin B Blood and blood forming organs → B03 Antianemic preparations → B03B Vitamin B12 and folic acid → B03BA Vitamin B12 (cyanocobalamin and analogues)
Discover more medicines within B03BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 143406, 28595
Country: IE Health Products Regulatory Authority Identifier(s): 35882

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.